UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund

A Equity Funds scheme from UTI Mutual Fund. Figures below are for the Direct · Growth plan (ISIN INF789F1AB22).

NAV ₹11.8494 on 16 November 2026.

Expense ratio

Total expense ratio 0.78% a year for the Direct · Growth plan, as AMFI published it on 29 October 2026: base expense ratio 0.46%, brokerage 0.01%, transaction costs 0.00%, statutory levies including GST 0.31%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year5.0%18.0%-14.6%-0.11-0.11

Too little NAV history for the 3, 5, 10-year figures.

Not ranked in its category: its category mixes funds too different to rank against one another.

Largest holdings

Top 10 (September 2026 disclosure). Company shares make up 100.1% of the portfolio.

  1. Laurus Labs Limited — 4.78%
  2. BSE Limited — 4.16%
  3. The Federal Bank Limited — 4.11%
  4. Multi Commodity Exchange of India Limited — 3.79%
  5. Bharat Forge Limited — 2.80%
  6. GE Vernova T&D India Limited — 2.56%
  7. Polycab India Limited — 2.47%
  8. Hitachi Energy India Limited — 2.45%
  9. Aurobindo Pharma Limited — 2.35%
  10. Welspun Corp Limited — 2.35%

Plans

Other funds in Equity Funds

All 88 funds in Equity Funds · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.